Independent research on chronic post-viral and post-vaccination illness. The clearance-and-tolerance framework, pathway mechanics, stratified biomarkers, and the natural compounds that act as levers within it.
Investigations into natural compounds, cellular health mechanisms, and evidence-based wellness protocols.
The most developed work on this site. A unified framework for chronic spike-related illness as systemic clearance and tolerance failure under persistent antigenic drive: pathway mechanics (mTOR, glymphatic, SIRT1), five mechanistic subtypes, a tiered biomarker matrix, and intervention protocols. Evidence-graded, primary-source, falsifiable.
Achs et al. (npj Vaccines, December 2025) concluded no excessive DNA impurities and no host-genome carryover. An independent re-mapping of the sequencing data they deposited (PRJNA1303864) shows the opposite: near-complete E. coli genomic DNA in four of five Comirnaty lots at 56-95x depth, whole circular plasmid in every lot, and an RNA:DNA hybrid footprint in their own fragment lengths. The method critique is McKernan, Speicher and Rose's. The deposit analysis is what this article adds.
Using the EMA's own BWP position paper (released under ASK-289849) and the public GenBank deposit OR134577.1, an independent annotation of the BNT162b2 plasmid. The SV40 footprint is 695 bp, the backbone traces to the 1981 pSV2 vector family, and the integration property has been documented for 45 years.
Guide to nobiletin and eriodictyol, potent citrus flavonoids that combat inflammation, support antioxidant defenses, and attenuate endotoxin-induced inflammatory signaling.
Your biology is unique. What helps one person recover may not help you or could make things worse. This framework guides you through systematic assessment and targeted interventions based on your specific health terrain.
Detection is not clearance. A December 2025 Stanford paper places EPO-EPOR signalling on type 1 conventional dendritic cells as the master switch between immune tolerance and immune activation. Read alongside the cGAS-STING DNA-sensing literature, it suggests an uncomfortable hypothesis: contaminant plasmid DNA in mRNA vaccines may be detected loudly and cleared quietly, because the tolerance gate downstream is open.
A companion to the spikeopathy pathways article. Five mechanism-based subtypes instead of one umbrella hypothesis, a four-tier UK biomarker matrix mapped to each subtype, and an explicit falsifiability section. The differentiator: nobody has tried comprehensive PASC subtyping by clearance/tolerance mechanism before.
The clearance-system failure hypothesis of spikeopathy. Two systems break together: mTOR-driven autophagy inside cells, and glymphatic flow between them. SIRT1/PGC-1α is the connecting axis. With 2025 DTI-ALPS imaging, the dual-mTOR model, and the levers that actually touch the cycle.
What the New Evidence Changes A Nature Biotechnology paper shows that dendritic-cell targeting, a foundational mRNA-LNP design assumption, is dispensable: immune protection proceeds through an alternative pathway the platform was not designed around. Cardiac detargeting technology of the miRNA target-site type has been described in the literature since 2006. It was not incorporated into the deployed products. ...
Comprehensive computational analysis reveals artificial codon preference changes in COVID-19 mRNA vaccines (Pfizer: 15%, Moderna: 35%) absent from all natural SARS-CoV-2 variants (0%).
Declaration of Purpose This article presents a bioinformatics validation of Jean-Claude Perez's Supracode methodology, enhanced with modern structural biology and frameshifting research. All data are from public sequences and peer-reviewed sources. ...
Manufacturing switch, DNA contamination, spike persistence, IgG4 immune tolerance, amyloid microclots, and regulatory failure converge on one conclusion: mRNA experiments must halt until safety is demonstrated.
The scientific case for pausing NIAID's intranasal whole-virus platforms: direct olfactory-nerve access to the brain, full structural proteins including spike, and the exact networks mapped in 2025 now running U.S. policy.